Results 41 to 50 of about 58,451 (152)

Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial

Cardiovascular Diabetology
Background Clinical trials have established the prognostic benefits of sodium‒glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) and heart failure (HF) with preserved ejection fraction (HFpEF), although the ...
Artem Ovchinnikov, Alexandra Potekhina, Anastasiia Filatova, Olga Svirida, Kristina Zherebchikova, Fail Ageev, Evgeny Belyavskiy   +6 more
doaj   +1 more source

Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundClinical benefits from His bundle pacing (HBP) in heart failure patients with preserved and reduced left ventricular ejection fraction are still inconclusive.
Weijian Huang, Lan Su, Shengjie Wu, Lei Xu, Fangyi Xiao, Xiaohong Zhou, Kenneth A. Ellenbogen   +6 more
doaj   +1 more source

Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction

Biomolecules, 2022
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the heart that gradually result in reduced cardiac output (HFrEF) and/or increased cardiac pressures at rest and under stress (HFpEF).
Federico Ferro, Renza Spelat, Camilla Valente, Paolo Contessotto   +3 more
doaj   +1 more source

Management of heart failure with preserved ejection fraction [PDF]

Australian Prescriber, 2020
Heart failure with preserved ejection fraction is a highly heterogenous disease. There is emerging evidence that treatment should be tailored to the individual’s associated comorbidities No current algorithms exist for the management of heart failure with preserved ejection fraction.
Gard, Emma, Nanayakkara, Shane, Kaye, David, Gibbs, Harry   +3 more
openaire   +2 more sources

Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundWorsening renal function (WRF) is associated with adverse outcomes in patients with heart failure. We investigated the predictors and prognostic value of WRF during admission, in patients with preserved ejection fraction (HFpEF) versus those ...
Jeehoon Kang, Jin Joo Park, Young‐Jin Cho, Il‐Young Oh, Hyun‐Ah Park, Sang Eun Lee, Min‐Seok Kim, Hyun‐Jai Cho, Hae‐Young Lee, Jin Oh Choi, Kyung‐Kuk Hwang, Kye Hun Kim, Byung‐Su Yoo, Seok‐Min Kang, Sang Hong Baek, Eun‐Seok Jeon, Jae‐Joong Kim, Myeong‐Chan Cho, Shung Chull Chae, Byung‐Hee Oh, Dong‐Ju Choi   +20 more
doaj   +1 more source

Heart Failure With Preserved Ejection Fraction and Obesity

JACC: Case Reports, 2020
This report describes a case of heart failure with preserved ejection fraction in a post-menopausal woman with obesity. The case highlights a metabolic phenotype of heart failure with preserved ejection fraction that commonly manifests in women, with the
Arjun Sinha, MD, Clyde W. Yancy, MD, Sanjiv J. Shah, MD, Sadiya S. Khan, MD   +3 more
doaj   +1 more source

Heart failure with preserved ejection fraction.

Journal of geriatric cardiology : JGC, 2013
Progressive aging of the population and prolongation of life expectancy have led to the rising prevalence of heart failure (HF). Despite the improvements in medical therapy, the mortality rate of this condition has remained unacceptably high, becoming the primary cause of death in the elderly population.
Whalley, Gillian, Rigolli, Marzia
openaire   +3 more sources

Immunology of heart failure with preserved ejection fraction. [PDF]

Expert Rev Clin Immunol
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterized by diastolic dysfunction, systemic comorbidities, and chronic low-grade inflammation. Emerging evidence suggests that immune dysregulation plays a central role in its pathophysiology. Both innate and adaptive immune responses contribute to myocardial remodeling,
Wang B, Jankauskas SS, Mone P, Varzideh F, Santulli G.   +4 more
europepmc   +4 more sources

A case report of a patient with heart failure with preserved ejection fraction presented as dysphagia

ESC Heart Failure, 2023
Dysphagia is a common clinical symptom in older people that can be attributed to a wide range of diseases, extending from neoplasm to gastroesophageal reflux diseases such as stroke or achalasia.
Elena Leonidou, Maria Ioannou, Petros Mavrommatis, Angeliki Mouzarou   +3 more
doaj   +1 more source

Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction

Biological Research, 2014
BACKGROUND: Left ventricular diastolic dysfunction is one of the main characteristics of heart failure patients with a preserved left ventricular ejection fraction.
Huan Zheng, Ye Li, Nanzi Xie
doaj   +1 more source